NewGenIVF Group Limited was incorporated in the British Virgin Islands on 26 January 2023. NewGenIVF focuses on providing fertility treatments to realize the dream of building a family, mainly providing two services, namely: (i) in vitro fertilization (" IVF ") treatment services, including traditional IVF and egg donation; and (ii) surrogacy and ancillary care services. Currently, they have three clinics: one in Thailand, one in Cambodia, and one in Kyrgyzstan. 

Newgenivf Group - Newgen to issue 2.5 mln Class A ordinary shares as consideration

NewGenIVF Group

Newgenivf Group - Newgen to issue 2.5 mln Class A ordinary shares as consideration

Newgenivf Group - Newgen ownership in K25.ai to increase to 13% after deal

Newgenivf Group - Newgen ownership in K25.ai to increase to 13% after deal

K25.ai closed its Series A funding round with a post-money valuation of $200 million, more than doubling its pre-money valuation in under 60 days. NewGenIVF Group Limited invested $10 million in K25.ai's Pre-A round, securing a 10% ownership stake. Following K25.ai's new valuation, NewGen's stake is now worth $20 million, generating a $10 million unrealized gain expected to be booked in 2026. Amber Group, a Singapore-based digital assets firm, provided strategic support for the investment.K25.ai has completed its Series A funding round with a post-money valuation of $200 million, marking a significant increase from its pre-money valuation less than two months prior [1]. The company’s valuation growth follows a $10 million investment from NewGenIVF Group Limited in the Pre-A round, which <a href="https://example.com">secured a 10% ownership stake</a> in K25.ai. As a result of the increased valuation, NewGenIVF’s stake is now valued at $20 million, representing a <a href="https://example.com">$10 million unrealized gain</a> that is projected to be recognized in 2026. Amber Group, a Singapore-based digital assets firm, <a href="https://example.com">provided strategic support for the investment</a>. The rapid appreciation in K25.ai’s valuation highlights strong investor confidence in the company’s growth trajectory and market potential. The development underscores the ongoing interest in AI-driven financial technology solutions and the broader digital assets sector.

K25.ai Closes Series A, Valued at $200 Million, Doubling Pre-A Valuation

NewGenIVF has announced a planned UAE-based venture for its advanced cell-sorting and cytometry platform, valued at $19mln. The platform aims to commercialize reproductive health and IVF services across the UAE and GCC markets. The company has appointed Nadeem Malik as Senior Strategic Advisor to lead commercialization efforts. The UAE IVF market is projected to grow from $270mln in 2024 to $444mln in 2030 with a CAGR of 8.5%. NewGenIVF shares closed Monday's trade up 7.78% at $1.49.

NewGenIVF Announces $19mln Valuation for UAE Cytometry Venture, Appoints Strategic Advisor

NewGenIVF Group Limited has announced a total outstanding share count of 10,073,535 and a market capitalization of $7,631,710. The company's net asset value as of December 31, 2025 was approximately $25.98 million, representing a substantial discount. NewGen has also invested $10 million in K25.ai, an AI-powered live-streaming prediction market platform, and has adopted a digital assets treasury strategy.NewGenIVF Group Limited has disclosed a total outstanding share count of 10,073,535, with a corresponding <a href="https://example.com">market capitalization of $7,631,710</a> as of June 22, 2026. This valuation reflects a significant discount to the company’s net asset value, which <a href="https://example.com">stood at approximately $25.98 million</a> as of December 31, 2025. The disparity between market capitalization and net assets may indicate market sentiment or valuation challenges.In addition to its core operations, NewGenIVF has made a <a href="https://example.com">$10 million investment in K25.ai</a>, an AI-powered live-streaming prediction market platform. This move aligns with the company’s broader digital assets treasury strategy, signaling a strategic pivot toward technology and digital innovation. Investors are advised to monitor the performance of this investment and its potential impact on the company’s financial position. The company’s financial disclosures provide a transparent view of its current status, offering stakeholders a factual basis for further analysis and decision-making.

NIVF News